CAGE Questionnaire for Alcohol: A Complete Guide to This Clinical Screening Tool

The CAGE questionnaire is one of the most widely recognized and frequently used screening instruments for identifying potential alcohol use problems. Developed by Dr. John A. Ewing in 1968 and first published in 1984, the CAGE is a brief, four-question tool designed to detect patterns of drinking behavior that may indicate alcohol misuse, dependence, or an alcohol use disorder (AUD).

The acronym CAGE is derived from the four questions it contains, each targeting a key behavioral or psychological marker associated with problematic drinking:

• C — Have you ever felt you should Cut down on your drinking?
• A — Have people Annoyed you by criticizing your drinking?
• G — Have you ever felt bad or Guilty about your drinking?
• E — Have you ever had a drink first thing in the morning to steady your nerves or to get rid of a hangover (Eye-opener)?

The CAGE questionnaire does not measure how much or how frequently a person drinks. Instead, it focuses on the consequences and subjective experiences associated with drinking — internal distress, interpersonal conflict, self-regulation attempts, and physiological dependence cues. This distinction is important: a person who drinks moderately by volume but experiences significant guilt, social friction, or a compulsion to drink in the morning may exhibit patterns consistent with a clinically meaningful problem.

Because of its brevity and simplicity, the CAGE has been integrated into primary care, emergency department, psychiatric, and surgical settings worldwide. It remains a cornerstone of opportunistic screening — the practice of identifying potential alcohol problems during routine clinical encounters rather than waiting for patients to self-refer.

The CAGE questionnaire was originally developed and validated for use with adult populations in medical and clinical settings. It is most commonly administered in:

• Primary care practices — as part of routine health screenings or annual exams
• Emergency departments — to identify alcohol-related presentations or underlying alcohol problems in patients presenting with injuries, accidents, or medical crises
• Psychiatric and behavioral health settings — during initial intake assessments or as part of a broader substance use evaluation
• Surgical and preoperative settings — to identify patients at risk for alcohol withdrawal during hospitalization
• Prenatal care — though specialized instruments like the T-ACE or TWEAK are often preferred for pregnant populations

The CAGE is not specifically validated for adolescents, and its utility in this population is limited. Adolescents typically have shorter drinking histories and may not yet have experienced the consequences captured by the CAGE questions. For younger populations, tools like the CRAFFT screening instrument are generally more appropriate.

It is also important to note that the original validation studies for the CAGE were conducted predominantly in male, medically hospitalized populations. Subsequent research has examined its performance across gender, racial, and ethnic groups with variable results, which is discussed in detail in the limitations section below.

The CAGE is intended as a screening instrument, not a diagnostic tool. A positive screen does not confirm a diagnosis of alcohol use disorder as defined by the DSM-5-TR. Rather, it identifies individuals who warrant further clinical evaluation, including a comprehensive substance use history, assessment of DSM-5-TR criteria, and consideration of co-occurring medical or psychiatric conditions.

One of the CAGE's greatest strengths is its ease of administration. The questionnaire consists of only four yes-or-no questions and can be completed in under one minute. It can be administered in several formats:

• Clinician-administered interview: A healthcare provider asks the four questions verbally during a clinical encounter. This is the most common administration method and allows the clinician to observe nonverbal cues, clarify responses, and embed the questions naturally within a broader clinical interview.
• Self-report questionnaire: The patient reads and answers the four questions on paper or electronically. This format can reduce social desirability bias in some patients who feel uncomfortable disclosing drinking behavior face-to-face.
• Embedded within structured intake forms: Many healthcare systems include the CAGE questions within broader health history or behavioral health screening forms completed during registration or intake.

When administered as part of an interview, clinicians are often advised to introduce the questions in a non-judgmental, matter-of-fact manner. Framing the questions as routine — "I ask all my patients these questions" — can reduce defensiveness and improve the accuracy of responses. Some clinicians also find it helpful to precede the CAGE with general questions about drinking frequency and quantity (e.g., "Do you sometimes drink beer, wine, or other alcoholic beverages?") to establish a conversational context before moving to the more probing CAGE items.

The questions refer to the patient's lifetime experience with alcohol, not just current or recent drinking. This is a deliberate design choice: individuals in early recovery, periods of abstinence, or denial about current use may still endorse past experiences that signal a problematic relationship with alcohol. However, some clinical protocols adapt the CAGE to focus on a specific time frame (e.g., the past 12 months) depending on the clinical context.

Scoring the CAGE questionnaire is straightforward. Each "yes" response receives 1 point, and each "no" response receives 0 points. The total score ranges from 0 to 4.

The standard interpretation guidelines are as follows:

• Score of 0: No identified alcohol-related concerns based on this screening. No further evaluation is indicated by this tool alone, though clinical judgment should always guide decision-making.
• Score of 1: A single positive response suggests possible risk and may warrant further inquiry, particularly if the endorsed item is the "Eye-opener" question, which is considered the most specific indicator of physiological dependence.
• Score of 2 or higher: This is the most widely used clinical cutoff. A score of 2 or more is considered a clinically significant positive screen and strongly suggests the need for a more comprehensive assessment of alcohol use and related problems.
• Score of 3–4: Higher scores are associated with a greater likelihood of alcohol dependence and more severe alcohol-related problems.

It is essential to understand that the CAGE score is a screening indicator, not a diagnosis. A score of 2 does not mean a person has an alcohol use disorder. It means the pattern of responses is consistent with features commonly associated with problematic alcohol use, and a thorough clinical evaluation is warranted.

Some researchers and clinicians have advocated for using a cutoff score of 1 in certain populations or settings — particularly in emergency departments, prenatal care, or when screening populations with lower base rates of alcohol problems — to increase sensitivity and reduce the chance of missing at-risk individuals. This lower threshold increases the detection of true positives but also increases false positives, requiring more follow-up evaluations.

The CAGE questionnaire has been extensively studied over several decades, and a substantial body of research supports its psychometric properties, particularly in medical settings.

Sensitivity and Specificity: Using the standard cutoff score of 2, research consistently reports sensitivity in the range of 70% to 96% and specificity in the range of 75% to 95% for detecting alcohol abuse or dependence, depending on the population studied and the diagnostic criteria used as the reference standard. A landmark meta-analysis by Dhalla and Kopec (2007) found that the CAGE demonstrated strong overall performance in identifying alcohol abuse and dependence in diverse clinical populations.

Reliability: Test-retest reliability and internal consistency for the CAGE have generally been reported as adequate, though as a four-item instrument with dichotomous responses, traditional reliability metrics like Cronbach's alpha are somewhat limited in what they can reveal. Studies have reported internal consistency coefficients ranging from approximately 0.75 to 0.85.

Comparative Performance: The CAGE has been compared extensively to other alcohol screening instruments, including the AUDIT (Alcohol Use Disorders Identification Test), MAST (Michigan Alcoholism Screening Test), and AUDIT-C. Research generally suggests that the AUDIT and AUDIT-C outperform the CAGE in detecting hazardous or at-risk drinking — drinking that has not yet reached the threshold of dependence but still poses health risks. The CAGE, by contrast, tends to perform better at detecting more established patterns of alcohol abuse and dependence.

This distinction has important clinical implications. The CAGE is most useful for identifying individuals whose drinking has already produced recognizable consequences — guilt, social conflict, attempts to cut down, morning drinking. It is less effective at identifying individuals in the earlier stages of risky alcohol use who might benefit from brief interventions.

Cross-Cultural Validation: The CAGE has been translated into numerous languages and validated in diverse cultural contexts. However, the interpretation of questions — particularly the "Annoyed" and "Guilty" items — can be influenced by cultural norms around alcohol use, shame, and interpersonal communication. Clinicians working with culturally diverse populations should consider these factors when interpreting results.

Despite its widespread use and historical significance, the CAGE has several well-documented limitations that clinicians should consider:

• Limited detection of hazardous drinking: The CAGE was designed to identify alcohol abuse and dependence, not risky or hazardous drinking patterns that fall below the threshold of a clinical disorder. Individuals who binge drink episodically but have not yet experienced the consequences captured by the CAGE items may screen negative. For this reason, many guidelines now recommend the AUDIT or AUDIT-C as a primary screening tool, particularly in settings focused on early intervention.
• Reduced sensitivity in certain populations: Research has demonstrated that the CAGE has lower sensitivity in women, younger adults, and some racial and ethnic minority groups. Women, for example, may be less likely to endorse the "Annoyed" question due to differences in how drinking is socially perceived and discussed. The original validation in predominantly white male medical inpatients limits generalizability.
• Lifetime framing may reduce specificity for current problems: Because the standard CAGE questions refer to lifetime experience, a person who had an alcohol problem 20 years ago but has been in sustained recovery may still screen positive. This can lead to unnecessary further evaluation or mislabeling if the context is not carefully considered.
• Susceptibility to denial and social desirability bias: As with any self-report screening instrument, the CAGE relies on honest disclosure. Individuals who minimize, deny, or lack insight into their drinking behavior may produce falsely negative results. This is a particular concern in forensic, occupational, or legal contexts where there may be incentives to underreport.
• Dichotomous response format limits nuance: The yes-or-no format does not capture the severity, frequency, or recency of the experiences described. Two people who both score 2 may have very different clinical presentations and needs.
• Does not assess quantity or frequency of drinking: The CAGE provides no information about how much or how often a person drinks. It should always be supplemented with questions about drinking patterns to form a complete clinical picture.

Given these limitations, many clinical guidelines — including those from the U.S. Preventive Services Task Force (USPSTF) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) — have shifted toward recommending the AUDIT-C or single-item screening questions as first-line tools in primary care, while acknowledging the CAGE's continued utility as a supplementary instrument.

In clinical practice, the CAGE questionnaire is used as a first-step screening tool within a larger assessment process. It is not used in isolation to make diagnostic or treatment decisions. Here is how CAGE results typically inform clinical workflows:

1. Triggering Further Assessment: A positive CAGE screen (score of 2 or higher) signals the clinician to conduct a more thorough evaluation. This typically includes a detailed substance use history — including quantity, frequency, duration, and pattern of alcohol use — as well as an assessment of DSM-5-TR criteria for alcohol use disorder. The DSM-5-TR defines AUD along a severity continuum: mild (2–3 criteria), moderate (4–5 criteria), or severe (6 or more criteria out of 11).

2. Informing Brief Interventions: In primary care and emergency department settings, a positive CAGE can trigger a brief intervention — a short, structured conversation about alcohol use, its risks, and the patient's readiness to change. The SBIRT model (Screening, Brief Intervention, and Referral to Treatment) is a widely implemented framework that uses screening results to guide clinical action.

3. Identifying Withdrawal Risk: In inpatient and surgical settings, a positive CAGE score alerts the treatment team to the possibility of alcohol withdrawal syndrome, which can be a medical emergency. This allows for appropriate monitoring, prophylaxis, and management protocols to be activated.

4. Guiding Referral Decisions: Patients who screen positive and are confirmed to have significant alcohol-related problems through further evaluation may be referred to specialized substance use treatment programs, addiction psychiatry, or mutual support groups. The CAGE result itself is not sufficient to determine the appropriate level of care, but it serves as an important data point in the referral decision.

5. Documentation and Longitudinal Tracking: In electronic health record systems, CAGE scores can be tracked over time to monitor changes in a patient's self-reported relationship with alcohol. However, because the standard CAGE refers to lifetime experiences, its utility for tracking change over time is limited compared to instruments like the AUDIT that assess a defined time frame.

The CAGE is one of several validated alcohol screening instruments available to clinicians. Understanding how it compares to alternatives helps clinicians choose the right tool for the right context:

• AUDIT (Alcohol Use Disorders Identification Test): Developed by the World Health Organization, the AUDIT is a 10-item questionnaire that assesses drinking quantity, frequency, and consequences over the past 12 months. It is considered superior to the CAGE for detecting hazardous and harmful drinking — not just dependence — and is currently recommended by many guidelines as the gold-standard screening tool. Its main drawback is that it takes longer to administer than the CAGE.
• AUDIT-C: The AUDIT-C consists of the first three consumption-focused questions of the full AUDIT. It is brief, well-validated, and effective at identifying both risky drinking and alcohol use disorders. Many experts consider it the best balance of brevity and sensitivity available.
• MAST (Michigan Alcoholism Screening Test): A 25-item (or shortened 13-item) questionnaire that predates the CAGE. It is comprehensive but lengthy, making it less practical for routine screening in busy clinical settings. It has largely been supplanted by shorter instruments.
• T-ACE and TWEAK: These instruments were specifically developed and validated for screening alcohol use during pregnancy. They modify or replace CAGE items to improve sensitivity in pregnant women.
• Single-Item Screening Questions: The NIAAA recommends a single pre-screening question: "How many times in the past year have you had 5 or more drinks in a day (4 or more for women)?" Any response of 1 or more triggers further assessment. This approach has demonstrated strong sensitivity and is increasingly used in primary care.

The choice of screening tool should be guided by the clinical setting, the target population, the specific clinical question, and practical constraints such as time and available resources. The CAGE remains a useful tool in many contexts, particularly when integrated with other assessment strategies.

The CAGE questionnaire is in the public domain and is freely available for clinical, educational, and research use. Unlike some proprietary instruments, there are no licensing fees or permissions required to use the CAGE.

The four CAGE questions can be found in:

• The original publication: Ewing, J.A. (1984). "Detecting Alcoholism: The CAGE Questionnaire." Journal of the American Medical Association, 252(14), 1905–1907.
• Numerous clinical guidelines and textbooks on addiction medicine, primary care, and psychiatry
• Online resources from institutions such as the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and various academic medical centers
• Many electronic health record (EHR) systems, which include the CAGE as a built-in screening module

Because the CAGE is so brief and widely known, it is frequently reproduced in clinical reference materials, medical education curricula, and patient intake forms. Clinicians implementing the CAGE should ensure they are using the exact original wording of the four questions, as modifications to question phrasing can affect the validity of the instrument.

If you or someone you know recognizes patterns described in the CAGE questionnaire — persistent feelings of guilt about drinking, attempts to cut down, conflict with others about alcohol use, or a need to drink in the morning — these experiences may align with features associated with an alcohol use problem, and a professional evaluation is strongly recommended.

A qualified healthcare provider — such as a primary care physician, psychiatrist, psychologist, or licensed counselor with experience in substance use — can conduct a comprehensive assessment, determine whether the criteria for alcohol use disorder are met, identify any co-occurring mental health conditions, and develop an individualized treatment plan.

Resources for immediate help include:

• SAMHSA National Helpline: 1-800-662-4357 (free, confidential, available 24/7)
• NIAAA Alcohol Treatment Navigator: alcoholtreatment.niaaa.nih.gov
• Crisis Text Line: Text HOME to 741741
• 988 Suicide and Crisis Lifeline: Call or text 988 if alcohol use is accompanied by suicidal thoughts or self-harm

Alcohol use disorder is a treatable medical condition. Effective, evidence-based treatments — including behavioral therapies, medications, and recovery support services — are available and can lead to significant improvements in health, functioning, and quality of life. Screening tools like the CAGE are a starting point, not an endpoint. The most important step is connecting with a professional who can provide a thorough evaluation and guide next steps.